Reuters logo
3 months ago
BRIEF-Delmar Pharmaceuticals announces Q3 loss per share $0.18
May 18, 2017 / 9:32 PM / 3 months ago

BRIEF-Delmar Pharmaceuticals announces Q3 loss per share $0.18

May 18 (Reuters) - Delmar Pharmaceuticals Inc

* Delmar Pharmaceuticals announces third quarter fiscal year 2017 financial results

* Q3 loss per share $0.18

* Delmar Pharmaceuticals Inc - Recent financing enables co to remain on-track to initiate pivotal phase 3 clinical trial of VAL-083 in refractory GBM

* Delmar Pharma - Current working capital, including proceeds from recent financing is sufficient to support planned operations for next 18-24 months Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below